|
CN1030415A
(zh)
*
|
1987-02-20 |
1989-01-18 |
山之内制药株式会社 |
饱和的杂环碳酰胺衍生物和它的制备方法
|
|
ES2005163A6
(es)
|
1987-04-14 |
1989-03-01 |
Lilly S A E |
Un procedimiento para la produccion de derivados de tiofen-2-carboxamida.
|
|
CA1336909C
(en)
|
1988-03-16 |
1995-09-05 |
Vittorio Vecchietti |
Heterocyclic derivatives
|
|
DE3810848A1
(de)
|
1988-03-30 |
1989-10-19 |
Boehringer Ingelheim Kg |
Neue 2,3,4-substituierte imidazole und 3,4,5-substituierte 1,2,4-triazole, ihre herstellung und verwendung
|
|
DE3927483A1
(de)
|
1989-08-19 |
1991-02-21 |
Boehringer Ingelheim Kg |
Neue substituierte heterocyclische fuenfringe, ihre herstellung und verwendung
|
|
US5258357A
(en)
*
|
1989-10-07 |
1993-11-02 |
Basf Aktiengesellschaft |
Carboxamides, their preparation and their use as herbicides
|
|
DE3933573A1
(de)
|
1989-10-07 |
1991-04-18 |
Basf Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
US6645969B1
(en)
|
1991-05-10 |
2003-11-11 |
Aventis Pharmaceuticals Inc. |
Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
|
|
US5559235A
(en)
|
1991-10-29 |
1996-09-24 |
Glaxo Wellcome Inc. |
Water soluble camptothecin derivatives
|
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
|
US5595872A
(en)
*
|
1992-03-06 |
1997-01-21 |
Bristol-Myers Squibb Company |
Nucleic acids encoding microsomal trigyceride transfer protein
|
|
US5342947A
(en)
|
1992-10-09 |
1994-08-30 |
Glaxo Inc. |
Preparation of water soluble camptothecin derivatives
|
|
AU674553B2
(en)
|
1992-10-14 |
1997-01-02 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
DE69325662T2
(de)
*
|
1992-10-23 |
2000-02-10 |
Merck Sharp & Dohme Ltd., Hoddesdon |
Dopamin rezeptor subtyp liganden
|
|
FR2707295A1
(fr)
|
1993-06-07 |
1995-01-13 |
Rhone Poulenc Agrochimie |
Fongicides pyrazoles substitués en position 3 par un hétérocycle.
|
|
EP0712397B1
(en)
*
|
1993-08-06 |
1999-04-21 |
Smithkline Beecham Plc |
Amide derivatives as 5ht1d receptor antagonists
|
|
US5739135A
(en)
*
|
1993-09-03 |
1998-04-14 |
Bristol-Myers Squibb Company |
Inhibitors of microsomal triglyceride transfer protein and method
|
|
US5681835A
(en)
|
1994-04-25 |
1997-10-28 |
Glaxo Wellcome Inc. |
Non-steroidal ligands for the estrogen receptor
|
|
US5491237A
(en)
|
1994-05-03 |
1996-02-13 |
Glaxo Wellcome Inc. |
Intermediates in pharmaceutical camptothecin preparation
|
|
US5668148A
(en)
*
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
|
JP3964478B2
(ja)
*
|
1995-06-30 |
2007-08-22 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ヘテロ環含有カルボン酸誘導体及びそれを含有する医薬
|
|
US5846990A
(en)
|
1995-07-24 |
1998-12-08 |
Bristol-Myers Squibb Co. |
Substituted biphenyl isoxazole sulfonamides
|
|
BR9606546A
(pt)
*
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
KR100423590B1
(ko)
*
|
1995-08-02 |
2004-09-10 |
호따. 우리아치에씨아. 에세. 아. |
항진균활성을갖는신규피리미돈유도체
|
|
DE69634822T2
(de)
|
1995-08-22 |
2006-04-27 |
Japan Tobacco Inc. |
Amid-verbindungen und ihre anwendung
|
|
US6001866A
(en)
*
|
1995-10-05 |
1999-12-14 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
WO1997012613A1
(en)
|
1995-10-05 |
1997-04-10 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5972980A
(en)
*
|
1995-10-05 |
1999-10-26 |
Warner-Lambert Company |
Method for treating and preventing inflammation and atherosclerosis
|
|
US5942544A
(en)
*
|
1996-02-22 |
1999-08-24 |
Dupont Pharmaceuticals Company |
α-branched anilines, toluenes, and analogs thereof as factor Xa inhibitors
|
|
JP2000507593A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
|
AU706497B2
(en)
|
1996-04-03 |
1999-06-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
CA2249650A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU706150B2
(en)
|
1996-04-03 |
1999-06-10 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU704792B2
(en)
|
1996-04-03 |
1999-05-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036881A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036898A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
EP0891333A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
WO1997036897A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AUPO163896A0
(en)
*
|
1996-08-14 |
1996-09-05 |
Resmed Limited |
Determination of respiratory airflow
|
|
WO1998037068A1
(en)
*
|
1997-02-21 |
1998-08-27 |
Bristol-Myers Squibb Company |
Benzoic acid derivatives and related compounds as antiarrhythmic agents
|
|
US5998336A
(en)
|
1997-02-26 |
1999-12-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Ceramic/metal and A15/metal superconducting composite materials exploiting the superconducting proximity effect and method of making the same
|
|
ATE334975T1
(de)
|
1997-05-30 |
2006-08-15 |
Takeda Pharmaceutical |
Sulfonamidderivate, ihre herstellung und verwendung
|
|
GB9716557D0
(en)
|
1997-08-06 |
1997-10-08 |
Glaxo Group Ltd |
Benzylidene-1,3-dihydro-indol-2-one derivatives having anti-cancer activity
|
|
DE19744026A1
(de)
|
1997-10-06 |
1999-04-08 |
Hoechst Marion Roussel De Gmbh |
Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
|
|
AU751139B2
(en)
*
|
1997-10-13 |
2002-08-08 |
Astellas Pharma Inc. |
Amide derivative
|
|
DE19882892T1
(de)
|
1997-12-12 |
2001-02-22 |
Euro Celtique Sa |
Herstellung von 3-substituierten Adeninen und Imidazopyridinen
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
AUPP433398A0
(en)
|
1998-06-25 |
1998-07-16 |
Australian National University, The |
Compounds and processes
|
|
US6192967B1
(en)
*
|
1998-10-19 |
2001-02-27 |
Sunny En Liung Huang |
Collapsible auto shade
|
|
US6130333A
(en)
|
1998-11-27 |
2000-10-10 |
Monsanto Company |
Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
|
|
GB9827882D0
(en)
|
1998-12-17 |
1999-02-10 |
Smithkline Beecham Plc |
Novel compounds
|
|
DE19904396A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Substituierte Pyrazolbenzylamin-Derivate
|
|
DE19904397A1
(de)
|
1999-02-04 |
2000-08-10 |
Bayer Ag |
Verwendung von Pyrazol-Carbonsäureamiden
|
|
JP2000256358A
(ja)
|
1999-03-10 |
2000-09-19 |
Yamanouchi Pharmaceut Co Ltd |
ピラゾール誘導体
|
|
TR200102944T2
(tr)
|
1999-04-13 |
2002-08-21 |
Basf Aktiengesellschaft |
İntegrin reseptör ligandları
|
|
EP1185509A2
(en)
*
|
1999-05-24 |
2002-03-13 |
Cor Therapeutics, Inc. |
INHIBITORS OF FACTOR Xa
|
|
JP2003500382A
(ja)
*
|
1999-05-24 |
2003-01-07 |
シーオーアール セラピューティクス インコーポレイテッド |
Ｘａ因子の阻害剤
|
|
JP2001247569A
(ja)
|
1999-08-12 |
2001-09-11 |
Japan Tobacco Inc |
ピロリジン誘導体又はピペリジン誘導体及びその医薬用途
|
|
US6632815B2
(en)
*
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
|
WO2001038309A1
(en)
|
1999-11-24 |
2001-05-31 |
Cor Therapeutics, Inc. |
β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa
|
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
|
EP1162196A4
(en)
|
1999-12-27 |
2003-04-16 |
Japan Tobacco Inc |
COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
|
|
WO2001056557A2
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of erk
|
|
HUP0202332A2
(en)
*
|
2000-02-05 |
2002-10-28 |
Vertex Pharma |
Pyrazole compositions useful as inhibitors of erk
|
|
CA2369076A1
(en)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compositions useful as inhibitors of erk
|
|
AU2001250783A1
(en)
*
|
2000-02-29 |
2001-09-12 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
|
GB0011098D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
Pharmaceutical compositions comprising protpn pump inhibitors and gastrin/cholecystokinin receptor ligands
|
|
AU6469401A
(en)
|
2000-05-19 |
2001-11-26 |
Serono Reproductive Biology In |
Pharmaceutically active compounds and methods of use
|
|
US6589195B1
(en)
*
|
2000-05-26 |
2003-07-08 |
Orthomerica Products, Inc. |
Modular adjustable prophylactic hip orthosis and adduction/abduction joint
|
|
AU2001268711A1
(en)
*
|
2000-06-23 |
2002-01-08 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
|
WO2002007823A2
(en)
|
2000-07-24 |
2002-01-31 |
Davide Riccardo Grassetti |
Inhibition of mutagenic effects of carcinogens
|
|
GB0018758D0
(en)
*
|
2000-07-31 |
2000-09-20 |
Smithkline Beecham Plc |
Novel use and compunds
|
|
JO2654B1
(en)
*
|
2000-09-04 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Multiple aryl caroxa amides are useful as lipid - lowering agents
|
|
WO2002064136A2
(en)
*
|
2001-01-26 |
2002-08-22 |
Chugai Seiyaku Kabushiki Kaisha |
Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
|
|
JP2004532234A
(ja)
*
|
2001-04-27 |
2004-10-21 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
トリアゾール由来キナーゼインヒビターおよびその使用
|
|
DE10223912A1
(de)
*
|
2001-06-28 |
2003-01-16 |
Merck Patent Gmbh |
TN- und STN-Flüssigkristallanzeigen
|
|
US20030015823A1
(en)
*
|
2001-07-18 |
2003-01-23 |
Hydranautics |
Method for forming a thick section, thermoset, solid casting
|
|
DE60226154T2
(de)
*
|
2001-08-03 |
2009-05-20 |
Vertex Pharmaceuticals Inc., Cambridge |
Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
|
|
ATE491701T1
(de)
*
|
2001-08-03 |
2011-01-15 |
Vertex Pharma |
Von pyrazol abgeleitete kinaseinhibitoren und deren verwendung
|
|
BR0212101A
(pt)
*
|
2001-08-24 |
2004-08-24 |
Pharmacia & Up John Company |
7-aza [2.2.1] biciclo-heptanos substituìdos com heteroarila para o tratamento de doenças
|
|
DK1441724T3
(da)
*
|
2001-09-27 |
2007-12-03 |
Serono Lab |
Fremgangsmåde til forögelse af endogene testosteronniveauer
|
|
US6794252B2
(en)
*
|
2001-09-28 |
2004-09-21 |
Texas Instruments Incorporated |
Method and system for forming dual work function gate electrodes in a semiconductor device
|
|
WO2003035619A1
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
|
WO2003039529A1
(en)
|
2001-11-07 |
2003-05-15 |
4Sc A.G. |
Selective antibacterial agents
|
|
TW200306819A
(en)
*
|
2002-01-25 |
2003-12-01 |
Vertex Pharma |
Indazole compounds useful as protein kinase inhibitors
|
|
EP1472245A2
(en)
*
|
2002-02-06 |
2004-11-03 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds useful as inhibitors of gsk-3
|
|
US7335779B2
(en)
|
2002-03-08 |
2008-02-26 |
Quonova, Llc |
Modulation of pathogenicity
|
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
|
GB0206861D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Medicaments
|
|
US20050154202A1
(en)
|
2002-04-05 |
2005-07-14 |
Hagmann William K. |
Substituted aryl amides
|
|
WO2003090751A1
(en)
*
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
|
|
AU2003240546A1
(en)
*
|
2002-06-05 |
2003-12-22 |
Pharmacia And Upjohn Company |
Methods for identifying ligands using competitive binding 1h nmr experiments
|
|
GB0216224D0
(en)
*
|
2002-07-12 |
2002-08-21 |
Glaxo Group Ltd |
Compounds
|
|
PL374970A1
(en)
|
2002-08-02 |
2005-11-14 |
Argenta Discovery Limited |
Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
|
|
MXPA05001592A
(es)
*
|
2002-08-09 |
2005-05-05 |
Astrazeneca Ab |
Oxadiazoles como moduladores de receptor-5 de glutamato metabotropico.
|
|
US6649638B1
(en)
*
|
2002-08-14 |
2003-11-18 |
Ppd Discovery, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
EP1534680B1
(en)
*
|
2002-08-14 |
2012-02-22 |
Pharmaco Investments, Inc. |
Prenylation inhibitors and methods of their synthesis and use
|
|
AU2003268184A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
|
DE10239443A1
(de)
|
2002-08-28 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Blockiervorrichtung für ein Sperrspannwerk mit federbetätigtem Abtrieb
|
|
EP1398029A1
(en)
*
|
2002-09-10 |
2004-03-17 |
LION Bioscience AG |
NR3B1 nuclear receptor binding 3-substituted pyrazole derivatives
|
|
EP1581527A4
(en)
|
2002-12-13 |
2006-11-22 |
Smithkline Beecham Corp |
MIMETICS OF THROMBOPOIETINE
|
|
CN1747949A
(zh)
|
2002-12-20 |
2006-03-15 |
法马西亚公司 |
无环吡唑化合物
|
|
JP2006517211A
(ja)
*
|
2003-02-10 |
2006-07-20 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
Ｐｇｉ２アンタゴニストとして使用するためのビス（ヘテロ）アリールカルボキサミド誘導体
|
|
WO2004072018A1
(ja)
|
2003-02-12 |
2004-08-26 |
Takeda Pharmaceutical Company Limited |
アミン誘導体
|
|
US7223788B2
(en)
*
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
EP1599447A1
(en)
*
|
2003-02-28 |
2005-11-30 |
Galderma Research & Development, S.N.C. |
Ligands that modulate lxr-type receptors
|
|
US7517887B2
(en)
|
2003-04-09 |
2009-04-14 |
General Atomics |
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
|
|
UY28280A1
(es)
|
2003-04-21 |
2004-11-30 |
Pharmacia & Amp |
2- hidroxi - 3- diaminoalcanos de benzamida
|
|
JP4716996B2
(ja)
*
|
2003-05-26 |
2011-07-06 |
武田薬品工業株式会社 |
スルホピロール
|
|
CA2529154C
(en)
|
2003-06-20 |
2013-05-07 |
Galderma Research & Development, S.N.C. |
Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
|
|
DE10331305A1
(de)
|
2003-07-10 |
2005-02-17 |
Siemens Ag |
Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht
|
|
FR2857666B1
(fr)
|
2003-07-15 |
2005-08-26 |
Oreal |
Composition tinctoriale comprenant a titre de coupleur un derive du furane et nouveaux derives du furane
|
|
CN1826121B
(zh)
|
2003-07-23 |
2013-05-29 |
幸讬制药公司 |
苯基与吡啶基衍生物用于制备调控钙离子释放活化钙离子通道的药物的用途
|
|
WO2005019200A2
(en)
|
2003-08-14 |
2005-03-03 |
Icos Corporation |
Aryl piperidine derivatives as vla-1 integrin antagonists and uses thereof
|
|
CA2536470A1
(en)
|
2003-08-15 |
2005-02-24 |
Vertex Pharmaceuticals Incorporated |
Pyrrole compositions useful as inhibitors of c-met
|
|
WO2005019182A1
(en)
|
2003-08-20 |
2005-03-03 |
Bayer Healthcare Ag |
Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
|
|
EP1689393A4
(en)
|
2003-10-06 |
2008-12-17 |
Glaxo Group Ltd |
PREPARATION OF 1,7-DISUBSTITUTED AZABENZIMIDAZOLES AS KINASE INHIBITORS
|
|
EP1670466A4
(en)
|
2003-10-06 |
2007-04-25 |
Glaxo Group Ltd |
PREPARATION OF 1,6,7-TRISUBSTITUTED AZABENIC ZIMIDAZOLES AS KINASE-INHIBITORS
|
|
US20050192314A1
(en)
*
|
2003-11-13 |
2005-09-01 |
Ambit Biosciences Corporation |
Urea derivatives as C-kit modulators
|
|
CA2546754A1
(en)
|
2003-11-21 |
2005-06-09 |
Array Biopharma Inc. |
Akt protein kinase inhibitors
|
|
US8652089B2
(en)
|
2004-01-19 |
2014-02-18 |
Arthrex, Inc. |
System for distending body tissue cavities by continuous flow irrigation
|
|
US20080293716A1
(en)
|
2004-01-30 |
2008-11-27 |
Smithkline Beecham Corporation |
Chemical Compounds
|
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
|
WO2005077373A2
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Treatment of gastro-esophageal reflux disease (gerd)
|
|
AR047894A1
(es)
|
2004-02-25 |
2006-03-01 |
Wyeth Corp |
Derivados de tiofeno como inhibidores de la proteina tirosina fosfatasa 1b (ptpasa 1b); metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades mediadas por ptpasa 1b
|
|
MXPA06010520A
(es)
*
|
2004-03-30 |
2007-03-26 |
Chiron Corp |
Derivados de tiofeno sustituidos como agentes anticancerosos.
|
|
JP2007531354A
(ja)
*
|
2004-03-30 |
2007-11-01 |
松下電器産業株式会社 |
コンテンツ中継サーバ、コンテンツ中継システム、コンテンツ中継方法及びそのプログラム
|
|
EP1730128A1
(en)
|
2004-03-31 |
2006-12-13 |
Exelixis, Inc. |
Anaplastic lymphoma kinase modulators and methods of use
|
|
JP2005336172A
(ja)
|
2004-04-26 |
2005-12-08 |
Japan Tobacco Inc |
腎虚血再灌流障害治療又は予防薬
|
|
TW200600492A
(en)
|
2004-05-18 |
2006-01-01 |
Achillion Pharmaceuticals Inc |
Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
|
|
US20080119456A1
(en)
*
|
2004-05-29 |
2008-05-22 |
Trond Ulven |
Substituted Thiazoleacetic Acid as Crth2 Ligands
|
|
EP1765332A2
(en)
*
|
2004-06-17 |
2007-03-28 |
Cengent Therapeutics, Inc. |
Trisubstituted nitrogen modulators of tyrosine phosphatases
|
|
WO2006004984A1
(en)
*
|
2004-06-30 |
2006-01-12 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of protein kinases
|
|
US7671077B2
(en)
*
|
2004-07-19 |
2010-03-02 |
Leu-Fen Hou Lin |
Neuroprotective small organic molecules, compositions and uses related thereto
|
|
US20060019967A1
(en)
*
|
2004-07-21 |
2006-01-26 |
Su-Ying Wu |
SARS CoV main protease inhibitors
|
|
US20060019968A1
(en)
*
|
2004-07-24 |
2006-01-26 |
Laboratorios Dr. Esteve S.A. |
Use of compounds active on the sigma receptor for the treatment of neuropathic pain
|
|
US7269099B2
(en)
|
2004-07-30 |
2007-09-11 |
Bolt Technology Corporation |
Air gun
|
|
JP2006066488A
(ja)
*
|
2004-08-25 |
2006-03-09 |
Mitsubishi Electric Corp |
半導体受光素子およびその製造方法
|
|
US7365385B2
(en)
*
|
2004-08-30 |
2008-04-29 |
Micron Technology, Inc. |
DRAM layout with vertical FETs and method of formation
|
|
US20060043513A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Deok-Hoon Kim |
Method of making camera module in wafer level
|
|
TW200616969A
(en)
|
2004-09-17 |
2006-06-01 |
Tanabe Seiyaku Co |
Imidazole compound
|
|
US20060062453A1
(en)
*
|
2004-09-23 |
2006-03-23 |
Sharp Laboratories Of America, Inc. |
Color highlighting document image processing
|
|
WO2006043518A1
(ja)
|
2004-10-18 |
2006-04-27 |
Santen Pharmaceutical Co., Ltd. |
神経疾患治療剤
|
|
JP2006120339A
(ja)
|
2004-10-19 |
2006-05-11 |
Matsushita Electric Ind Co Ltd |
高周波加熱電源装置
|
|
TW200619843A
(en)
|
2004-10-20 |
2006-06-16 |
Sumitomo Bakelite Co |
Semiconductor wafer and semiconductor device
|
|
DE102004051277A1
(de)
|
2004-10-21 |
2006-04-27 |
Merck Patent Gmbh |
Heterocyclische Carbonylverbindungen
|
|
DE102004054666A1
(de)
|
2004-11-12 |
2006-05-18 |
Bayer Cropscience Gmbh |
Substituierte Pyrazol-3-carboxamide, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren
|
|
CN101048383A
(zh)
|
2004-11-23 |
2007-10-03 |
惠氏公司 |
促性腺激素释放激素受体拮抗剂
|
|
CA2588961A1
(en)
*
|
2004-11-30 |
2006-06-08 |
Neurosearch A/S |
Novel diazabicyclic aryl derivatives as cholinergy ligands
|
|
SE527990C2
(sv)
|
2004-12-06 |
2006-08-01 |
Mora Of Sweden Ab |
Isborr
|
|
AU2006210503B2
(en)
|
2005-02-03 |
2009-09-03 |
Irm Llc |
Compounds and compositions as PPAR modulators
|
|
JP2006232707A
(ja)
|
2005-02-23 |
2006-09-07 |
Japan Tobacco Inc |
癌転移抑制剤
|
|
WO2006110762A2
(en)
|
2005-04-11 |
2006-10-19 |
Achillion |
Pharmaceutical compositions for and methods of inhibiting hcv replication
|
|
US20060252807A1
(en)
*
|
2005-04-22 |
2006-11-09 |
Kalypsys, Inc. |
Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
|
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
|
JP2008543919A
(ja)
|
2005-06-21 |
2008-12-04 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
|
US20060288588A1
(en)
|
2005-06-22 |
2006-12-28 |
Frank Morabito |
Garden tool
|
|
JP5345842B2
(ja)
*
|
2005-06-23 |
2013-11-20 |
アステックス・セラピューティクス・リミテッド |
プロテインキナーゼモジュレーターとしてのピラゾール誘導体を含む医薬組み合わせ
|
|
MA28394B1
(fr)
|
2005-06-24 |
2007-01-02 |
Genelabs Tech Inc |
Derives d'heteroaryle pour traitement des virus
|
|
WO2006136637A2
(es)
*
|
2005-06-24 |
2006-12-28 |
Eloy Antonio Martinez Albal |
Implante dental de corona rotatoria
|
|
US8703805B2
(en)
|
2005-06-27 |
2014-04-22 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
CN100494167C
(zh)
|
2005-08-02 |
2009-06-03 |
天津大学 |
抗乙肝病毒的叔胺氧化物及制备方法和制备药物的应用
|
|
GB0518237D0
(en)
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
WO2007052843A1
(ja)
|
2005-11-04 |
2007-05-10 |
Takeda Pharmaceutical Company Limited |
複素環アミド化合物およびその用途
|
|
US7838676B2
(en)
*
|
2005-11-21 |
2010-11-23 |
Amgen Inc. |
Beta-secretase modulators and methods of use
|
|
AU2006325746A1
(en)
|
2005-12-14 |
2007-06-21 |
Bristol-Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
|
WO2007076423A2
(en)
|
2005-12-22 |
2007-07-05 |
Smithkline Beecham Corporation |
INHIBITORS OF Akt ACTIVITY
|
|
SI1962830T1
(sl)
|
2005-12-23 |
2013-07-31 |
Glaxosmithkline Llc |
Azaindolni inhibitorji kinaz Aurora
|
|
AR056882A1
(es)
|
2006-02-01 |
2007-10-31 |
Bayer Cropscience Sa |
Derivados del fungicida n- cicloalquil- bencil- amida
|
|
CN101484424B
(zh)
|
2006-02-28 |
2014-05-14 |
达特神经科学(开曼)有限公司 |
治疗化合物
|
|
JP2007277230A
(ja)
|
2006-03-15 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
CA2673299C
(en)
|
2006-12-21 |
2016-04-12 |
Sloan-Kettering Institute For Cancer Research |
Pyridazinone compounds for the treatment of proliferative diseases
|
|
CA2671766A1
(en)
|
2006-12-22 |
2008-07-03 |
Encysive Pharmaceuticals, Inc. |
Modulators of c3a receptor and methods of use thereof
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
WO2008098105A1
(en)
|
2007-02-07 |
2008-08-14 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
|
WO2008121685A1
(en)
|
2007-03-28 |
2008-10-09 |
Smithkline Beecham Corporation |
Methods of use for inhibitors of akt activity
|
|
WO2008121786A1
(en)
|
2007-03-29 |
2008-10-09 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|